CSL earnings preview: why CSL is optimistic about its annual earnings
Over the last six months, CSL has managed to overcome market woes by surpassing set benchmarks. Its share price had jumped over 20% while the ASX 200 was down 2%.
CSL Limited release date:
CSL Ltd is expected to release its earnings report on Wednesday, August 17, 2022.
CSL Limited earnings expectation:
- NPAT: US $2.26 billion
- EPS: 6.938 (-4% YOY)
- DPS: 3.075 (-22% YOY)
CSL Limited earnings key watch:
After three years of an average annual earning of 6.14% compared to the industry average of 9.21%, analysts estimate CSL’s annual growth to increase to 7.49% between 2022 and 2023. The optimism is well earned as CSL sold a record volume of 110 million doses of seasonal influenza vaccines in the northern hemisphere.
With plasma collections now well above pre-covid levels and plasma donor fees reduced, this news bodes well for a healthy margin despite inflation headwinds. Furthermore, the power of the CSL brand has allowed the company to increase the price of its products by near double digits without hurting demand.
In terms of the biotech company’s outlook, CSL tips EPS growth of 17% for FY23 and a total shareholder return of 15% over the next 12 months with plasma collections expected to continuously improve and deliver strong revenue growth.
CSL share price and technical analysis:
Over the last six months, CSL has overcome market woes by surpassing set benchmarks. Its share price had jumped over 20% while the ASX 200 was down 2%.
From a technical viewpoint, the share price for CSL was slightly lower after prices failed to clear the $300 psychological level in July. However, the price is still hovering around the year high level. The recently breached 20-day Simple Moving Average (SMA) may put some pressure on the prices while the. MACD and RSI have fallen back to the avaerage but remain above the 50 midpoints.
A break above the trend line would call for a new attempt of the $300 threshold while a move below $289 would erase all the gain from early July.
CSL Limited daily chart
The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.
Start trading forex today
Find opportunity on the world’s most-traded – and most-volatile – financial market
- Trade spreads from just 0.6 points on EUR/USD
- Analyse with clear, fast charts
- Speculate wherever you are with our intuitive mobile apps
See an FX opportunity?
Try a risk-free trade in your demo account, and see whether you’re onto something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See an FX opportunity?
Don’t miss your chance – upgrade to a live account to take advantage.
- Get spreads from just 0.6 points on popular pairs
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See an FX opportunity?
Don’t miss your chance. Log in to take your position.
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
